DESCRIPTION: (Adapted from the applicant's abstract.) The proposed studies
are directed to an examination of the mechanism of endothelial cell
retraction. The hypothesis directing this work is that endothelial cell
(EC) retraction requires two events for the formation of retractive gaps:
a dissolution or gel-sol transition in the cortical cytoplasm and the
activation of the EC contractile apparatus. Ethchlorvynol (ECV), a
chemical mediator which causes Adult Respiratory Distress Syndrome (ARDS),
and histamine and thrombin, two important mediators of inflammation that
increase vascular permeability will be used to test their hypothesis. A
tissue culture model utilizing human vein and bovine pulmonary artery
endothelial cells will be used to simulate the retraction that occurs in
vivo in ARDS. The studies have been designed to determine if retraction
and gap formation are associated with EC myosin light chain
phosphorylation. The relationships between MLC phosphorylation, cytosolic
Ca2 positive, cellular deformability and monolayer permeability will be
determined. In addition, the enzymes (MLCK or PKC or both) responsible for
phosphorylating MLC in agonist stimulated monolayers will be identified.
Elevation of cyclic adenosine monophosphate and the use of synthetic
peptide inhibitors to myosin light chain kinase will be employed to inhibit
EC retraction, MLC phosphorylation and cellular deformability. The role of
gelsolin, a Ca2 positive activated actin severing protein, in the changes
in the structure of the actin network will be investigated. The group will
correlate the EGTA resistant 1:1 actin/gelsolin complexes and actin
severing activity from agonist stimulated monolayers. The time course for
formation of actin/gelsolin complexes and actin severing activity will be
compared with Ca2 positive mobilization, cellular deformability and EC
retraction. The permeabilized EC preparation will be used to test the
effects of gelsolin on EC retraction. Varying concentrations of gelsolin
will be added to these preparations and the effect on the actin network and
retraction determined. Confocal fluorescence microscopy will be used to
define the three-dimensional characteristics of the actin network with
particular attention to the peripheral rim of actin. The structure of the
cytoskeleton in resting and stimulated EC will be defined with respect to
the disposition of actin, myosin, MLCK and gelsolin.
No Sub Projects information available for 5R29HL045788-05
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R29HL045788-05
Patents
No Patents information available for 5R29HL045788-05
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R29HL045788-05
Clinical Studies
No Clinical Studies information available for 5R29HL045788-05
News and More
Related News Releases
No news release information available for 5R29HL045788-05
History
No Historical information available for 5R29HL045788-05
Similar Projects
No Similar Projects information available for 5R29HL045788-05